April 24th 2024
Study from the Journal of Hepatology aims to characterize immune responses associated with rapid natural clearance of HCV reinfection.
FDA Expands Use of Vemlidy to Adolescents with Chronic HBV Infection
December 5th 2022Children as young as 12 can now receive tenofovir alafenamide for treatment of chronic hepatitis B virus infection with compensated liver disease, after the US Food and Drug Administration expanded the indication for the drug.
Read More